All lobbying filings

NVG, LLC

Lobbying for NOVO NORDISK INC. · Pharmaceutical company

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 19, 2025

Income

$140,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare coverage of Anti-Obesity Medicines.

Health Issues

Issues related to pharmaceutical supply chain transparency and integrity. Issues relating to pharmaceutical drug pricing. Issues related to compounding and counterfeit medicines.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.